Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8894803 | 1.00 | GGT1 (0.44) | GGT1TGFBR1CPB2CPB1 | |
| SCHEMBL10724429 | 0.84 | GGT1 (0.46) | GGT1CPB2CPB1 | |
| SCHEMBL28581575 | 0.82 | GGT1 (0.58) | GGT1TGFBR1CPB2CPB1 | |
| SCHEMBL880551 | 0.82 | GGT1 (0.58) | GGT1TGFBR1CPB2CPB1 | |
| SCHEMBL21206958 | 0.80 | TGFBR1 (0.36) | TGFBR1 | |
| SCHEMBL4759293 | 0.80 | GGT1 (0.43) | GGT1CPB2CPB1 | |
| SCHEMBL27902177 | 0.78 | GGT1 (0.46) | GGT1CPB2CPB1 | |
| SCHEMBL16382140 | 0.77 | GGT1 (0.41) | GGT1TGFBR1CPB2CPB1 | |
| SCHEMBL9802585 | 0.75 | EPHX1 (0.41) | — | |
| SCHEMBL3095619 | 0.75 | ANPEP (0.35) | TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5681543-A | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI | SHERING AKTIENGESELLSCHAFT (DE) | 1997-10-28 | — | — | US | disclosed |
| US-5681544-A | Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-10-28 | — | — | US | disclosed |
| US-5482700-A | Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-09 | — | — | US | disclosed |
| EP-0331616-B1 | Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same | SCHERING AG (DE) | 1995-11-08 | — | — | EP | disclosed |
| EP-0305320-B1 | MULTINUCLEIC SUBSTITUTED COMPLEXANTS, COMPLEXES AND COMPLEX SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-09-23 | — | — | EP | disclosed |
| EP-0357622-A1 | SUBSTITUTED COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURE THEREOF AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-03-14 | — | — | EP | disclosed |
| EP-0355097-A1 | SUBSTITUTED CYCLIC COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURING SAME, AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-02-28 | — | — | EP | disclosed |
| EP-0331616-A2 | Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0305320-A2 | Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-03-01 | — | — | EP | disclosed |
| WO-1988008422-A1 | SUBSTITUTED CYCLIC COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURING SAME, AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-11-03 | — | — | WO | disclosed |
| WO-1988007521-A1 | SUBSTITUTED COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURE THEREOF AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-10-06 | — | — | WO | disclosed |